Orchid allows parents to screen their embryos' odds for breast cancer, irritable bowel syndrome, and obesity. How dystopian.

Genetic risk for schizophrenia is tied to thinner retinas, suggesting retinal scans could aid early detection and treatment.

Are substance-induced psychosis and primary psychosis fundamentally different? And if they are, does it matter?

Compared with placebo, xanomeline/trospium as an add-on to atypical antipsychotics has not reached the threshold for a ...

On the heels of a clinical setback for Bristol Myers Squibb’s schizophrenia newcomer Cobenfy, the New Jersey pharma is ...

Despite a dip in sales and a recent schizophrenia stumble, the company drew an optimistic outlook for sales for the rest of ...

The pharmaceutical company on Thursday said it raised its full-year guidance for revenue in the year to a range of $45.8 billion to $46.8 billion, up from a previous forecast of $45.5 billion.

A new study led by scientists from the University of Zurich and the University Hospital of Psychiatry Zurich has found a ...

In the phase III ARISE trial, adjunctive xanomeline and trospium chloride (Cobenfy) were no better than placebo at improving ...

U.S. stock indexes rallied at midday Wednesday as President Donald Trump said he has "no intention" of firing Federal Reserve ...

Autism's history is filled with misconceptions. Understanding the science helps us move past outdated myths, support autistic ...